FAQ: NeuralBase Submits HeartEase App for Google Play Store Review

What is the HeartEase app?

The HeartEase app is an innovative, AI-powered mobile application designed to provide users with real-time insights and personalized guidance for heart health.

Why is the submission of HeartEase to the Google Play Store significant?

This submission represents a major milestone in making AI-driven healthcare support accessible to Android users globally, aligning with NeuralBase’s vision to reach everyone on every platform.

How does the HeartEase app work?

The app delivers advanced health and wellness support through AI, offering personalized heart health guidance and real-time insights to users.

Who is behind the development of the HeartEase app?

NeuralBase AI Ltd., operating under its enterprise brand BMP AI, is the company behind the HeartEase app, focusing on secure, scalable, and context-aware conversational systems and workflow automation.

When will the HeartEase app be available on the Google Play Store?

The app is currently under review by Google Play, and NeuralBase will provide an update once the review process is complete and the app is published.

Will the HeartEase app be available for iOS users?

Following the Android release, NeuralBase plans to proceed with final testing and submission of the iOS version to the Apple App Store to ensure broad accessibility.

What are the future plans for NeuralBase AI Ltd.?

NeuralBase aims to expand its AI-driven healthcare support across all platforms, enhancing team collaboration, productivity, and maintaining compliance and data security through its BMP AI platform.

Where can I find more information about NeuralBase AI Ltd.?

Additional information is available at NeuralBase’s website (https://www.neuralbase.ai) or through the SEC’s EDGAR database (https://www.sec.gov).

What should potential investors know about NeuralBase AI Ltd.?

Investing in NeuralBase involves risks such as potential loss of principal, low liquidity, and high volatility, with shares traded on the OTC Markets under the ticker symbol NBBI.